{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:12:51Z","timestamp":1790208771590,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01PS005204-01-00"],"award-info":[{"award-number":["U01PS005204-01-00"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Integration of a sensitive point-of-care (POC) HIV viral load (VL) test into screening algorithms may help detect acute HIV infection earlier, identify people with HIV (PWH) who are not virally suppressed, and facilitate earlier referral to antiretroviral therapy (ART), or evaluation for pre-exposure prophylaxis (PrEP). This report describes a randomized clinical trial sponsored by the Centers for Disease Control and Prevention (CDC): \u201cEnding the HIV Epidemic Through Point-of-Care Technologies\u201d (EHPOC). The study\u2019s primary aim is to evaluate the use of a POC HIV VL test as part of a testing approach and assess the impact on time to linkage to ART or PrEP. The study will recruit people in Baltimore, Maryland, including patients attending a hospital emergency department, patients attending an infectious disease clinic, and people recruited via community outreach. The secondary aim is to evaluate the performance characteristics of two rapid HIV antibody tests approved by the United States Food and Drug Administration (FDA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study will recruit people 18 years or older who have risk factors for HIV acquisition and are not on PrEP, or PWH who are not taking ART. Participants will be randomly assigned to either the control arm or the intervention arm. Participants randomized to the control arm will only receive the standard-of-care (SOC) HIV screening tests. Intervention arm participants will receive a POC HIV VL test in addition to the SOC HIV diagnostic screening tests. Follow up will consist of an interim phone survey conducted at week-4 and an in-person week-12 visit. Demographic and behavioral information, and oral fluid and blood specimens will be collected at enrollment and at week-12. Survey data will be captured in a Research Electronic Data Capture (REDCap) database. Participants in both arms will be referred for either ART or PrEP based on their HIV test results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The EHPOC trial will explore a novel HIV diagnostic technology that can be performed at the POC and provide viral assessment. The study may help inform HIV testing algorithms and contribute to the evidence to support same day ART and PrEP recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>NIH ClinicalTrials.gov NCT04793750. Date: 11 March 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08459-7","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:03:03Z","timestamp":1693569783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohammad Harris","family":"Bayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Smalls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agha W.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Pasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe O","family":"Demko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Eshleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba H.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Gonzalez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pollyanna R.","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"MacGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari C.","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"issue":"9903","key":"8459_CR1","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0140-6736(13)61998-4","volume":"382","author":"MS Cohen","year":"2013","unstructured":"Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? The Lancet. 2013;382(9903):1515\u201324.","journal-title":"The Lancet"},{"issue":"4","key":"8459_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/COH.0b013e32833a0d3a","volume":"5","author":"WC Miller","year":"2010","unstructured":"Miller WC, Rosenberg NE, Rutstein SE, Powers KA. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5(4):277\u201382.","journal-title":"Curr Opin HIV AIDS"},{"issue":"9","key":"8459_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the Prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"8459_CR4","doi-asserted-by":"publisher","first-page":"E114","DOI":"10.1016\/S2352-3018(20)30256-3","volume":"8","author":"SE Rowan","year":"2020","unstructured":"Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. The Lancet HIV. 2020;8(2):E114\u2013E20.","journal-title":"The Lancet HIV"},{"issue":"5","key":"8459_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.tibtech.2011.01.007","volume":"29","author":"A Niemz","year":"2011","unstructured":"Niemz A, Ferguson TM, Boyle DS. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol. 2011;29(5):240\u201350.","journal-title":"Trends Biotechnol"},{"key":"8459_CR6","unstructured":"Centers for Disease Control and Prevention. FDA Approved HIV Tests. https:\/\/www.cdc.gov\/hiv\/testing\/laboratorytests.html: Centers for Disease Control and Prevention; 2020."},{"issue":"1","key":"8459_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcv.2012.01.022","volume":"54","author":"P Patel","year":"2012","unstructured":"Patel P, Bennett B, Sullivan T, Parker MM, Heffelfinger JD, Sullivan PS. Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J Clin Virol. 2012;54(1):42\u20137.","journal-title":"J Clin Virol"},{"issue":"1","key":"8459_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-med-092112-143017","volume":"66","author":"H Shafiee","year":"2015","unstructured":"Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, et al. Emerging Technologies for Point-of-Care Management of HIV infection. Annu Rev Med. 2015;66(1):387\u2013405.","journal-title":"Annu Rev Med"},{"issue":"5","key":"8459_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"RW Eisinger","year":"2019","unstructured":"Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection. JAMA. 2019;321(5):451.","journal-title":"JAMA"},{"issue":"6","key":"8459_CR10","doi-asserted-by":"publisher","first-page":"e0218369","DOI":"10.1371\/journal.pone.0218369","volume":"14","author":"CA Agutu","year":"2019","unstructured":"Agutu CA, Ngetsa CJ, Price MA, Rinke de Wit TF, Omosa-Manyonyi G, Sanders EJ, et al. Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care. PLoS ONE. 2019;14(6):e0218369.","journal-title":"PLoS ONE"},{"issue":"3","key":"8459_CR11","doi-asserted-by":"publisher","first-page":"e0193577","DOI":"10.1371\/journal.pone.0193577","volume":"13","author":"Z Ndlovu","year":"2018","unstructured":"Ndlovu Z, Fajardo E, Mbofana E, Maparo T, Garone D, Metcalf C, et al. Multidisease testing for HIV and TB using the GeneXpert platform: a feasibility study in rural Zimbabwe. PLoS ONE. 2018;13(3):e0193577.","journal-title":"PLoS ONE"},{"issue":"10","key":"8459_CR12","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/S2352-3018(17)30097-8","volume":"4","author":"KG Technau","year":"2017","unstructured":"Technau KG, Kuhn L, Coovadia A, Murnane PM, Sherman G. Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study. Lancet HIV. 2017;4(10):e442\u2013e8.","journal-title":"Lancet HIV"},{"issue":"12","key":"8459_CR13","doi-asserted-by":"publisher","first-page":"e0209778","DOI":"10.1371\/journal.pone.0209778","volume":"13","author":"VS Opollo","year":"2018","unstructured":"Opollo VS, Nikuze A, Ben-Farhat J, Anyango E, Humwa F, Oyaro B, et al. Field evaluation of near point of care Cepheid GeneXpert HIV-1 qual for early infant diagnosis. PLoS ONE. 2018;13(12):e0209778.","journal-title":"PLoS ONE"},{"issue":"3","key":"8459_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/QAI.0000000000002340","volume":"84","author":"R Silhol","year":"2020","unstructured":"Silhol R, Boily M-C, Dimitrov D, German D, Flynn C, Farley JE, et al. Understanding the HIV Epidemic among MSM in Baltimore: a modeling study estimating the impact of Past HIV Interventions and who acquired and contributed to infections. J Acquir Immune Defic Syndr. 2020;84(3):253\u201362.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"8459_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/QAI.0000000000002962","volume":"90","author":"A Queiroz","year":"2022","unstructured":"Queiroz A, Mongrella M, Keiser B, Li DH, Benbow N, Mustanski B. Profile of the portfolio of NIH-Funded HIV implementation Research Projects to inform ending the HIV Epidemic Strategies. JAIDS J Acquir Immune Defic Syndr. 2022;90(1):23\u2013S31.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"4","key":"8459_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1086\/318711","volume":"32","author":"SD Mehta","year":"2001","unstructured":"Mehta SD, Rothman RE, Kelen GD, Quinn TC, Zenilman JM. Clinical aspects of diagnosis of gonorrhea and Chlamydia infection in an acute care setting. Clin Infect Dis. 2001;32(4):655\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8459_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/sti.2007.027029","volume":"84","author":"S Rogers","year":"2008","unstructured":"Rogers S, Miller W, Turner C, Ellen J, Zenilman J, Rothman R, et al. Concordance of chlamydia trachomatis infections within sexual partnerships. Sex Transm Infect. 2008;84(1):23\u20138.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"8459_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.annemergmed.2018.09.012","volume":"74","author":"CA Gaydos","year":"2019","unstructured":"Gaydos CA, Ako M-C, Lewis M, Hsieh Y-H, Rothman RE, Dugas AF. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for women in the Emergency Department can improve clinical management: report of a Randomized Clinical Trial. Ann Emerg Med. 2019;74(1):36\u201344.","journal-title":"Ann Emerg Med"},{"issue":"20","key":"8459_CR19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association Declaration of Helsinki","year":"2013","unstructured":"World Medical Association Declaration of Helsinki. JAMA. 2013;310(20):2191.","journal-title":"JAMA"},{"issue":"7","key":"8459_CR20","doi-asserted-by":"publisher","first-page":"e1002357","DOI":"10.1371\/journal.pmed.1002357","volume":"14","author":"SP Koenig","year":"2017","unstructured":"Koenig SP, Dorvil N, D\u00e9vieux JG, Hedt-Gauthier BL, Riviere C, Faustin M, et al. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial. PLoS Med. 2017;14(7):e1002357.","journal-title":"PLoS Med"},{"key":"8459_CR21","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Clinicalinfo.gov; 2019. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/initiation-antiretroviral-therapy?view=full."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08459-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T17:05:37Z","timestamp":1700499937000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8459"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08459-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HHM has research collaborations with Roche and Bio-Rad and serves on the advisory board for SeeGene. YCM has received research grant support to Johns Hopkins University from Hologic, Cepheid, Roche, ChemBio, Becton Dickinson, miDiagnostics, and has provided consultative feedback to Abbott on one occasion. MMH has received honoraria from Roche and GSK. All other authors, MHB, TS, AB, AM, CP, ZD, RER, YHH, SE, NGJ, PRC, BE, KPD, DD, and RJM, declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All study procedures will be performed in accordance with the relevant guidelines and regulations of the Declaration of Helsinki. Study participants will only engage in research activities after providing signed informed consent. The informed consent process will include the research coordinators explaining all study procedures to the potential participants and allowing sufficient time for reading the consent form and asking any questions the potential participants might have. This clinical trial will not enroll anyone under the age of 18. This clinical trial has been approved, and any future amendments will be approved, by the JHU institutional review board after discussion with the funder. The reference number is IRB00274090.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"570"}}